Resumen

JULIAO-BANOS, Fabián  y  LUQUEZ-MINDIOLA, Adán. Eosinophilic Esophagitis: State of the Art in 2024. Rev. colomb. Gastroenterol. [online]. 2024, vol.39, n.4, pp.435-446.  Epub 03-Feb-2025. ISSN 0120-9957.  https://doi.org/10.22516/25007440.1276.

Eosinophilic esophagitis (EoE) is an immune-mediated and allergic disease categorized as a primary eosinophilic gastrointestinal disorder. Its incidence and prevalence have increased over the past decades, alongside growing awareness of the condition among gastroenterologists. EoE is more common in young males with a history of atopy. Diagnostic criteria include symptoms and esophageal histology showing a count of ≥15 eosinophils per high-power field or > 60 eosinophils/mm², with eosinophilia restricted to the esophagus and other causes of eosinophilia excluded. Treatment follows the “3 Ds” approach: diet, drugs, and endoscopic dilation. Recently approved biological therapies, such as dupilumab, and novel therapeutic strategies are under investigation for managing this condition.

Palabras clave : Eosinophilic esophagitis; esophagitis; eosinophilia; diagnosis; treatment.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )